" Optimi Health Corp (CSE:OPTI) completes expansion of on-site analytical laboratory
Optimi Health (OPTI) has expanded the analytical laboratory at its Princeton, British Columbia facility.
" Clearmind Medicine (CSE:CMND) and SciSparc Ltd., collaboration yields new provisional patent application
Clearmind Medicine (CMND) filed a provisional patent application resulting from its recently launched collaboration with SciSparc Ltd. (NASDAQ: SPRC).
" Optimi Health (CSE:OPTI) expands psilocybin production capacity via license amendment
Optimi Health Corp. (OPTI) has been granted an amendment to its controlled substances dealer’s licence by Health Canada.
" Nirvana (CSE:NIRV) reports progress with dealer’s license application and facility development
Nirvana Life Sciences (NIRV) has provided an update to investors regarding the licensing and development application for its Vancouver lab facility.
" Red Light Holland (CSE:TRIP) sponsors group microdosing concert in the Netherlands
Red Light Holland Corp. (TRIP) has announced its sponsorship of a groundbreaking group microdosing concert.
" Red Light Holland (CSE:TRIP) expands its mushroom farms division with farmland purchase
Red Light Holland Corp. (TRIP) has signed a purchase and sales agreement to acquire 100 acres of farmland in Peterborough, Ontario for $1.85M.
" Psyched Wellness (CSE:PSYC) mushroom studies show anti-inflammatory effects
Psyched Wellness (PSYC) has shared preliminary data from studies on the neuroprotective properties of the AME-1 extract.
" Nirvana (CSE:NIRV) progresses psychedelic dealer’s license and facility development
Nirvana Life Sciences (NIRV) reports progress with licensing and development of its Vancouver research and development facility.
" Optimi Health (CSE:OPTI) begins cultivation of natural psilocybin for clinical trials
Optimi Health (OPTI) has commenced the cultivation of natural GMP-grade psilocybin mushrooms at its Princeton, British Columbia facility.